CASI Pharmaceuticals Inc/ KYG1933S1012 /
| 2024-04-25 10:00:00 PM | Chg. -0.1400 | Volume | Bid12:04:20 AM | Ask12:04:20 AM | High | Low |
|---|---|---|---|---|---|---|
| 2.3000USD | -5.74% | 27,760 Turnover: 51,687.7344 |
2.2500Bid Size: 1,000 | 3.8700Ask Size: 200 | 2.6100 | 2.2200 |
GlobeNewswire
2021-09-30
Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Senior Vice President
GlobeNewswire
2021-08-18
Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2019-04-10
Research Report Identifies CASI Pharmaceuticals, WestRock, H. B. Fuller, Osisko Gold Royalties, Kopi...
GlobeNewswire
2019-02-20
Report: Developing Opportunities within Pure Storage, Flowers Foods, Cognex, CASI Pharmaceuticals, E...
GlobeNewswire
2018-08-27
Factors of Influence in 2018, Key Indicators and Opportunity within Steelcase, SecureWorks, Clevelan...
GlobeNewswire
2018-06-25
Report: Exploring Fundamental Drivers Behind Cabot Oil & Gas, Chesapeake Lodging Trust, CASI Pharmac...
